Genenta Science (GNTA)

• Market cap: $60M
• 1 day: -0.39%
• 5 days: -24.48%
• 1 month: -22.42%
• 3 months: -30.81%
• 6 months: -38.61%
• Year to date: -43.49%
• 1 year: -51.7%
• 5 years: -76.73%
• 10 years: -76.73%
• Sector: Healthcare
• Industry: Biotechnology

About: Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Employees: 13